Having the 'Nrf2' Switch Pays Off: Kirin Gives Reata $35M Up Front - BioWorld Online PDF Print
BioWorld OnlineLtd. Kirin, of Tokyo, is a leader in Asian renal drugs, and made deals in the space with US powerhouse Amgen Inc., of Thousand Oaks, Calif., when the latter ...Reata Pharmaceuticals Licenses Chronic Kidney Disease Drug Bardoxolone Methyl

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.